NDC 51662-1220
Dopamine Hci 40 mg per 1 mL injection, solution, concentrate
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Hospira, Inc.'s NDC 0409-9104.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- Sep 4, 2026 · Class II · Pfizer
Lack of Assurance of Sterility
Lots: Lot # NL5230, Exp Date:10/2027
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Dopamine: every company that makes it
- Form
- injection, solution, concentrate, intravenous
- Strength
- 40 mg per 1 mL
- Approval
- NDA NDA018132
- On the market since
- Aug 23, 2018
- Package NDCs
51662-1220-151662-1220-251662-1220-3- Official label
- DailyMed (National Library of Medicine), updated Feb 22, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?